PATENT CLAIM ANALYSIS

Application Number: 15752635
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "265100"]

Abstract:
Janus kinase 1 selective inhibitors and pharmaceutical use thereof are provided.

Claim (Index 20):
A method of treating a disease associated with a JAK in a subject, the method comprising administering a therapeutically effective amount of the compound according to  claim 3  or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof to the subject.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15507409', '14183946', '13928696', '14715046', '13859569']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7639880537196202
- 35 USC 102 Novelty (BERT): 0.5552896116133983
- Combined Prediction Score: 0.7431182095089981
- Mean Citation Score: 368.18293400000016
- Max Citation Score: 425.25983
- Similarity Product: 307.5241176451159

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test